CORAL GABLES, Fla. (AP) — CORAL GABLES, Fla. (AP) — Catalyst Pharmaceutical Partners Inc. (CPRX) on Wednesday reported a loss of $30.8 million in its third quarter.
The Coral Gables, …
Join our family of readers for as little as $5 per month and support local, unbiased journalism.
Already have an account? Log in to continue. Otherwise, follow the link below to join.
Please log in to continue |
CORAL GABLES, Fla. (AP) — CORAL GABLES, Fla. (AP) — Catalyst Pharmaceutical Partners Inc. (CPRX) on Wednesday reported a loss of $30.8 million in its third quarter.
The Coral Gables, Florida-based company said it had a loss of 29 cents per share. Losses, adjusted for one-time gains and costs, came to 24 cents per share.
The specialty drug company posted revenue of $102.7 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $100.2 million.
Catalyst expects full-year revenue in the range of $390 million to $395 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CPRX at https://www.zacks.com/ap/CPRX
